Optimal [qlco]
Design [acty]
Patient Selection [resa]
intervention trials [resa]
Using [ftcn]
Biomarkers [clna]
Consortium [prog]
Statement [idcn]
Optimal [qlco]
Design [acty]
Patient Selection [resa]
intervention trials [resa]
First [qnco]
Sight [orgf]
Not [ftcn]
Give [ftcn]
Binary [qlco]
Information [idcn]
g% [qnco]
Mutation [genf]
Biomarkers [clna]
Risk [qlco]
Severe [qlco]
side effects [ftcn]
Continuous [idcn]
increasing incidence [ftcn]
side effects [ftcn]
High dose [qnco]
volumes [qnco]
Addition [ftcn]
Assay [lbpr]
Predicted [idcn]
Probability [qnco]
side effects [ftcn]
One [qnco]
More [ftcn]
Cutoff [ftcn]
thresholds [qlco]
classifying [clas]
Risk [qlco]
Discrete [qlco]
Categories [inpr]
Classical [qlco]
Biomarker [clna]
Trial Design [inpr]
Not [ftcn]
Optimal [qlco]
Risk factor [qnco]
Stratification [resa]
Approach [spco]
More [ftcn]
Appropriate [qlco]
Patient Selection [resa]
Based [ftcn]
Dose [qnco]
Response [orga]
Relations [socb]
Specific [qlco]
End Point [qlco]
Alternative [cnce]
Standard [qlco]
treatment [ftcn]
Available [ftcn]
Take [hlca]
account [idcn]
Preferences [idcn]
Patients [podg]
This [euka]
Detail [qlco]
[c] [qnco]
Ireland [geoa]
LTD [ortf]
Rights [qlco]
Reserve [acty]
